Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;49(6):734-40.
doi: 10.1007/s00120-009-2064-7.

[Locally recurrent prostate cancer following radiation therapy: radical salvage prostatectomy]

[Article in German]
Affiliations
Review

[Locally recurrent prostate cancer following radiation therapy: radical salvage prostatectomy]

[Article in German]
A Heidenreich et al. Urologe A. 2010 Jun.

Abstract

Radical salvage prostatectomy represents a secondary local treatment with curative intent in patients with organ-confined prostate cancer (PC) recurrences following radiation therapy. Preoperative risk factors predicting organ-confined disease are initial low dose rate (LDR) brachytherapy, preoperative Gleason biopsy score<or=6, <or=50% biopsy cores involved with cancer, and a prostate-specific antigen (PSA) doubling time>12 months. Metastatic disease should be ruled out preoperatively by skeletal scintigraphy, abdominal computed tomography or magnetic resonance imaging, and/or choline-PET/CT. Functionality of the lower urinary tract needs to be preoperatively evaluated by urethrocystoscopy and urodynamics. With appropriate patient selection, oncological control can be achieved in 80% of patients. A continence rate of 83%-96% depending on the type of previous radiation therapy is achievable.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Urol. 1997 Mar;157(3):921-5 - PubMed
    1. Urology. 1999 Jan;53(1):2-10 - PubMed
    1. Br J Urol. 1995 Jan;75(1):44-7 - PubMed
    1. Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):609-15 - PubMed
    1. Lancet. 2002 Jul 13;360(9327):103-6 - PubMed

MeSH terms

Substances

LinkOut - more resources